Studies on HIV/AIDS Among Students: Bibliometric Analysis (Preprint)

Wang, Na; Zhang, Runxi; Ye, Zeyan; Lan, Guanghua; Zhu, Qingqing; Chen, Huanhuan; Zhang, Xiangjun; Tan, Shengkui; Ruan, Yuhua; Lin, Mei

doi:10.2196/preprints.46042

Cited by 1 publication

(1 citation statement)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Network pharmacology and molecular docking simulation were performed according to a previously described protocol (Ruan et al, 2023 ). The overlapping targets of VLZ action and thrombocytopenia were obtained from the SwissTargetPrediction, DisGeNET and GeneCards databases.…”

Section: Network Pharmacology and Molecular Docking Simulationmentioning

confidence: 99%

Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia

Zhou,

Ni,

Liao

et al. 2024

Preprint

View full text Add to dashboard Cite

Thrombocytopenia caused by long-term radiotherapy and chemotherapy exists in cancer treatment. Previous research demonstrates that 5-Hydroxtrayptamine (5-HT) and its receptors induces the formation of megakaryocytes (MKs) and platelets. However, the relationships between 5-HT1A receptor (5-HTR1A) and MKs is unclear so far. We screened and investigated the mechanism of vilazodone as a 5-HTR1A partial agonist in promoting MK differentiation and evaluated its therapeutic effect in thrombocytopenia. We employed a drug screening model based on machine learning (ML) to screen the megakaryocytopoiesis activity of VLZ. The effects of Vilazodone (VLZ) on megakaryocytopoiesis were verified in HEL and Meg-01 cells. Tg (itga2b: eGFP) zebrafish was performed to analyze the alterations in thrombopoiesis. Moreover, we established a thrombocytopenia mice model to investigate VLZ administration accelerates platelet recovery and function. We carried out network pharmacology, Western blotting and immunofluorescence to demonstrate the potential targets and pathway of VLZ. VLZ has been predicted to have a potential biological action. Meanwhile, VLZ administration promotes MK differentiation and thrombopoiesis in cells and zebrafish models. Progressive experiments showed that VLZ has a potential therapeutic effect on radiation-induced thrombocytopenia in vivo . The network pharmacology and associated mechanism study indicated that SRC and MAPK signaling are both involved in the processes of megakaryopoiesis facilitated by VLZ. Furthermore, the expression of 5-HTR1A during megakaryocyte differentiation is closely related to the activation of SRC and MAPK. Our findings demonstrated that the expression of 5-HTR1A on MK, VLZ could bind to the 5-HTR1A receptor and further regulate the SRC/MAPK signaling pathway to facilitate megakaryocyte differentiation and platelet production, which provides new insights into the alternative therapeutic options for thrombocytopenia.

show abstract

Section: Network Pharmacology and Molecular Docking Simulationmentioning

confidence: 99%